top of page

jumbo phages have expanded genomes conferring them unique
biological properties, of high
potential to develop novel
Therapeutics targeting diseases mediated by bacteria 

News & PRess

jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png
jumbo_kinzbio.png

> nov '23

Nova awards winner

Uruguayan Innovation Awards: Recognition in the Startup Category

Kinzbio won the NOVA Award in the StartUp category for its contributions to the field of antimicrobial research. Specifically recognized for their pioneering work in "Jumbo Phages for the Development of New Anti-bacterial Tools and Other Biomedical Applications."
 

The NOVA Awards by ANII aim to celebrate impactful initiatives, foster an innovative culture across diverse sectors, and highlight success stories that underscore Uruguay's capacity for innovation.
 

This acknowledgment serves as motivation, inspiring us to persist in our innovative pursuits for a better world.

image.png
Swiss-knife-Victorinox-Work-Champ-21-fun

unleashing the potential of
Jumbo phages
together

Kinzbio fosters collaborations and partnerships with pharma leaders, clinical organizations, academic labs and funding agencies to help the company to accelerate the development of its jumbo phage platform and pipeline.

Kinzbio has an open communication channel with and is always seeking to hear from industry partners and funding institutions interested in joining efforts to keep developing applications based on the biology of jumbo phages.
 

BE IN

TOUCH

Please fill your contact details below:

Thanks for contact us!

Phage technologies for a

healthier world

Microbiome_edited.png

MODERN LIFESTYLE
Is weakening the
human microbiome

giving room to
pathogens that spread
antimicrobial resistance
and promote inflammation

phages are natural
bacterial killers
that can be used to
combat these pathogens

3305040.png
3305040.png
c1ece665a7319e22602d0d90426d3be5_edited_
3305040.png
3305040.png
3305040.png
News
Partnering
Contact
bottom of page